
Fortumax Pharma Private Limited
About Fortumax Pharma Private Limited
Data last updated:
Fortumax Pharma Private Limited is a private limited company based in Pune, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 12 December 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN U74999PN2017PTC173809. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Nagnath Lokare and Swapna Orikee.
Its last annual general meeting (AGM) was held on 31 December 2018, and its latest financial statements are for the year ended 31 March 2018. The registered office is at Shop No. 2 Glandale Building Riverdale Varale Talegaon Dabhade, Pune, Maharashtra, India – 410507.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Fortumax Pharma Private Limited's registered office is in Pune, Maharashtra.
- Registered AddressShop No. 2 Glandale Building Riverdale Varale Talegaon Dabhade, Pune, Maharashtra, India – 410507
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Fortumax Pharma Private Limited
FY 2018 filings availableFinancial Statement Summary
| Metrics | FY 2017-18 |
|---|---|
| Profit and Loss Statement | |
| Revenue from Operations | |
| Other Income | |
| Total Revenue | |
| Cost of Materials Consumed | |
| Employee Benefit Expense | |
| Finance Costs | |
| Depreciation and Amortisation | |
| Other Expenses | |
| Total Expenses | |
| EBITDA | |
| Profit Before Tax | |
| Tax Expense | |
| Net Profit (PAT) | |
| Balance Sheet | |
| Share Capital | |
| Reserves and Surplus | |
| Net Worth (Total Equity) | |
| Long-term Borrowings | |
| Short-term Borrowings | |
| Trade Payables | |
| Total Liabilities | |
| Fixed Assets | |
| Investments | |
| Inventories | |
| Trade Receivables | |
| Cash and Bank Balance | |
| Total Assets | |
Financial Ratios
| Metrics | FY 2017-18 |
|---|---|
| Profitability | |
| EBITDA Margin | |
| Net Profit Margin | |
| Return on Equity (ROE) | |
| Return on Capital Employed (ROCE) | |
| Return on Assets (ROA) | |
| Liquidity and Debt | |
| Current Ratio | |
| Quick Ratio | |
| Debt-to-Equity Ratio | |
| Interest Coverage Ratio | |
| Efficiency and Growth | |
| Asset Turnover | |
| Receivable Days | |
| Payable Days | |
| Inventory Days | |
| Revenue Growth | |
| Net Profit Growth | |
To see the full financial statements and ratios of Fortumax Pharma Private Limited, buy the company report.
Board of directors of Fortumax Pharma Private Limited
Fortumax Pharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nagnath Lokare | Director | 12 Dec 2017 | 8 Years 11 Months | Current |
| Swapna Orikee | Director | 12 Dec 2017 | 8 Years 11 Months | Current |
Legal cases
No court or tribunal cases involving Fortumax Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Fortumax Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Fortumax Pharma has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Fortumax Pharma Private Limited, buy the company report.
Recent activity
Fortumax Pharma Private Limited has 2 board changes on record since 2017: 2 appointments. The latest: Nagnath Lokare was appointed as Director on 12 Dec 2017.
Frequently asked questions
Fortumax Pharma is an active private limited company based in Pune, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 12 December 2017 (9+ years old) and is registered under CIN U74999PN2017PTC173809.
Fortumax Pharma has 2 current directors:
- Nagnath Lokare - Director
- Swapna Orikee - Director
The latest financial statements of Fortumax Pharma on record with the MCA are for the year ended 31 March 2018. Its last annual general meeting was held on 31 December 2018. Year-wise statements from FY 2018 are in the company report.
No. Fortumax Pharma has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Fortumax Pharma is U74999PN2017PTC173809. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Fortumax Pharma was incorporated on 12 December 2017, making it 9+ years old. It is registered with the Registrar of Companies, Pune.
Nagnath Lokare was appointed as Director on 12 Dec 2017. Swapna Orikee was appointed as Director on 12 Dec 2017.
The registered office of Fortumax Pharma is at Shop No. 2 Glandale Building Riverdale Varale Talegaon Dabhade, Pune, Maharashtra, India – 410507.
Fortumax Pharma operates in the pharma industry, in the drug formulation and development segment.
The compliance status of Fortumax Pharma is compliant as of 23 July 2026. The company is actively filing with the Registrar of Companies.

